002030.SZ
Daan Gene Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 5.39
−3.75%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−16.8x
Market Cap
CNY 7.57B
MomentumView details →
1D Return
−3.75%
YTD Return
−9.40%
RSI (14)
45.6
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−16.8x
Market Cap
CNY 7.57B
RSI (14)
45.6
MomentumView details →
1D Return
−3.75%
YTD Return
−9.40%
Similar companies
Latest newsMore news →
Da An Gene announced its first-half 2026 results, reporting a net loss of 120 million yuan, an improvement from a loss of 182 million yuan in the same period of 2025.8d agoDa An Gene and others jointly established Zhongda Synthetic Biotechnology (Guangzhou) Co., Ltd., a new company focused on synthetic biology research and development.12d ago